Drug Database
Back to search

Netherlands· NL-0915782206a1

Aqneursa 1 g granulaat voor orale suspensie in sachet

A levacetylleucine product containing levacetylleucine, registered in Netherlands by Intrabio Ireland Limited. The same ATC class is registered in 7 of our 19 countries.

ATC N07XX27

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedAqneursa 1 g granulaat voor orale sus…ATCN07XX27REGISTER NO.NL-0915782206a1PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about levacetylleucineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Levacetylleucine is registered in 7 of 19 countries.

Countries holding a registration under ATC N07XX27 (levacetylleucine), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 5 of them publish a price we can compare per daily dose
Search levacetylleucine products by name

Levacetylleucine · ATC N07XX27

7 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
LEVACETYLLEUCINE
Manufacturer
Intrabio Ireland Limited
Country
Netherlands (NL)
ATC code
N07XX27
ATC class
Levacetylleucine
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/25/1928

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Levacetylleucine in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All levacetylleucine products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Aqneursa
  • Liechtenstein · Aqneursa
  • Norway · Aqneursa

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/595f8234-643f-4ccc-874d-9477c47e78a8
GET /v1/drugs/595f8234-643f-4ccc-874d-9477c47e78a8?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Granulaat voor orale suspensie",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "www.ema.europa.eu/en/documents/product-information/aqneursa-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Levacetylleucine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp133700",
  "excipients": [
    "AARDBEIENSMAAKSTOF",
    "ARABISCHE GOM (E 414)",
    "AZIJNZUUR (E 260)",
    "HYPROMELLOSE 2910 (Release controlling polymer), E4M (E 464)",
    "ISOMALT (E 953)",
    "MALTODEXTRINE",
    "PROPYLEENGLYCOL (E 1520)",
    "WATER, GEZUIVERD"
  ],
  "substances": [
    "LEVACETYLLEUCINE"
  ],
  "leaflet_url": null,
  "authorised_at": "2026/01/19",
  "procedure_number": "EMEA/H/C/006327",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/25/1928",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about levacetylleucine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console